Literature DB >> 6822649

Negative feedback suppression of sleep-related growth hormone secretion.

W B Mendelson, L S Jacobs, J C Gillin.   

Abstract

Previous studies have demonstrated that injections of growth hormone (GH) can blunt subsequent GH secretory responses to daytime pharmacological stimulation. The current study was undertaken to determine whether GH administration to normal subjects would suppress sleep-related secretion. GH (2 U im) was given nine times over 5 days to each of six subjects, and sleep studies with blood sampling were performed 6 h after the last injection. Secretion during the first 2 h of sleep was decreased by 62.4%, indicating that sleep-related GH secretion may be responsive to a negative-feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822649     DOI: 10.1210/jcem-56-3-486

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.

Authors:  S M Rosenthal; J A Hulse; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 2.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

3.  Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Authors:  C B Webb; M L Vance; M O Thorner; G Perisutti; J Thominet; J Rivier; W Vale; L A Frohman
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

4.  Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men.

Authors:  M Cappa; S Setzu; S Bernardini; D Carta; G Federici; A Grossi; S Loche
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

5.  Physiological levels of growth hormone fail to suppress growth hormone releasing hormone (1-29) NH2-stimulated growth hormone secretion in man.

Authors:  C Brain; D N Thakrar; P C Hindmarsh; C G Brook
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

6.  Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone.

Authors:  I Gil-Ad; B Klinger; A Pertzelan; B Erster; A Silbergeld; H Talpaz; Z Laron
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.